General Information |
| Clinical trials phase |
Phase 2 |
| Start date (estimated) |
2022-06-10 |
| End date (estimated) |
2024-03-10 |
| Clinical feature |
| Label |
adult acute respiratory distress syndrome |
| Link |
http://purl.obolibrary.org/obo/MONDO_0100130 |
| Description |
A very severe form of acute pulmonary failure secondary to capillary permeability impairment. The symptoms include dyspnea, hypotension and multivisceral failure. The disease is characterized by bilateral pulmonary infiltrates and severe hypoxemia due to increased alveolar-capillary permeability. The severity depends on the degree of alveolar epithelial injury, with a mortality rate of 30-50%. |
|
Administrative Information |
| ICTRP weblink |
https://www.chictr.org.cn/showproj.html?proj=172317 |
| Other study identifiers |
| Name |
ChiCTR2200061436 |
| Description |
Chinese Clinical Trial Registry (ChiCTR) |
|
| Source weblink |
https://www.chictr.org.cn/showproj.html?proj=172317 |
| Sponsors |
China-Japan Friendship Hospital
|
Cells |
Recruitment |
| Recruitment Status |
Not yet recruiting |
| Estimated number of participants |
72 |
